Cocrystal Pharma (COCP) Prepaid Assets (2010 - 2026)
Cocrystal Pharma (COCP) posted Prepaid Assets of $418000.0 for Q1 2026, up 27.44% sequentially from $328000.0 in Q4 2025, and up 8.57% YoY from $385000.0 in Q1 2025.
Cocrystal Pharma (COCP) Prepaid Assets (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Prepaid Assets for 17 years, with the latest figure at $418000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 8.57% year-over-year to $418000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $418000.0 (up 8.57% YoY) and the FY2025 annual result came in at $328000.0, down 23.72% from the prior year.
- Prepaid Assets rose to $418000.0 in Q1 2026 per COCP's latest filing, from $328000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.8 million in Q3 2022 and troughed at $282000.0 in Q2 2025.
- A 5-year average of $1.1 million and a median of $509000.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 322.13% in 2023, then slumped 82.28% in 2024.
- Over 5 years, Prepaid Assets stood at $2.2 million in 2022, then decreased by 20.95% to $1.8 million in 2023, then sank by 75.75% to $430000.0 in 2024, then declined by 23.72% to $328000.0 in 2025, then gained by 27.44% to $418000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $418000.0, $328000.0, and $465000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 256,000.00 |
| Mar 31, 2026 | 418,000.00 |
| Dec 31, 2025 | 328,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 282,000.00 |
| Mar 31, 2025 | 385,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 365,000.00 |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | 2.77 Mn |
| Jun 30, 2022 | 488,000.00 |
| Mar 31, 2022 | 560,000.00 |
| Dec 31, 2021 | 568,000.00 |
| Sep 30, 2021 | 747,000.00 |